Analysis of the improvement effect of the abdominal symptom by the proton pump inhibitor for patients recieved chemotherapy

Analysis of the improvement effect of the abdominal symptom by the proton pump inhibitor for patients recieved chemotherapy - Effect of proton pump inhibitor for patients received chemotherapy

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000003077

Enrollment

Registered

2010-01-22

Start date

2010-01-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colon cancer patients received chemotherapy

Interventions

omeprazole 10mg sid 4weeks

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who fills everything the following 1)Colon cancer patients received chemotherapy 2)Patients who gives written informed consent 3)Patients received upper endoscopy within 1 year.

Exclusion criteria

Exclusion criteria: 1)Patients with peptic ulcers 2)Patients with severe GERD 3)Patients who has past history of allergy for the drugs used in this study 4)Patients with severe heart disease, liver disease,or renal disease 5)Pregnant females 6)Lacting woman 7)Patients who has past history of allergy for the drugs used in this study 4)Patients who has coexisting severe disease 5)Patient whom examination doctor judged improper as testee

Design outcomes

Primary

Measure	Time frame
Comparison of subjective symptom by a questionnaire	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026